RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A
- PMID: 18592002
- PMCID: PMC2434205
- DOI: 10.1593/neo.08312
RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A
Abstract
More than half of all colorectal carcinomas are known to exhibit an activated mitogen-activated protein kinase pathway. The NF1 gene, a negative regulator of KRAS, has not previously been examined in a series of colorectal cancer. In the present study, primary colorectal carcinomas stratified according to microsatellite instability status were analyzed. The whole coding region of NF1 was analyzed for mutations using denaturing high-performance liquid chromatography and sequencing, and the copy number alterations of NF1 were examined using multiple ligation-dependent probe amplification and real-time polymerase chain reaction. The mutational hot spots in KRAS and BRAF were sequenced, and promoter hypermethylation status of RASSF1A was assessed with a methylation-specific polymerase chain reaction. One sample had two missense mutations in NF1, whereas nine additional tumors had intronic mutations likely to affect exon splicing. Interestingly, 8 of these 10 tumors were microsatellite-unstable. Four other tumors showed a duplication of NF1. Mutations in KRAS and BRAF were mutually exclusive and were present at 40% and 22%, respectively. RASSF1A was hypermethylated in 31% of the samples. We show that the RAS signaling network is extensively dysregulated in colorectal carcinomas, because more than 70% of the tumors had an alteration in one or more of the four examined components.
Figures
Similar articles
-
Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.Oncogene. 2005 Nov 17;24(51):7630-4. doi: 10.1038/sj.onc.1208906. Oncogene. 2005. PMID: 16007118
-
Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.Int J Cancer. 2004 Apr 10;109(3):377-84. doi: 10.1002/ijc.11722. Int J Cancer. 2004. PMID: 14961576
-
Frequent involvement of ras-signalling pathways in both polypoid-type and flat-type early-stage colorectal cancers.J Exp Clin Cancer Res. 2006 Jun;25(2):235-42. J Exp Clin Cancer Res. 2006. PMID: 16918136
-
Frequent hypermethylation of RASSF1A in early flat-type colorectal tumors.Oncogene. 2004 Nov 25;23(55):8900-7. doi: 10.1038/sj.onc.1207993. Oncogene. 2004. PMID: 15480433
-
Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.Gut. 2009 Sep;58(9):1234-41. doi: 10.1136/gut.2008.159137. Epub 2009 May 26. Gut. 2009. PMID: 19474002
Cited by
-
Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin.BMC Cancer. 2010 Oct 27;10:587. doi: 10.1186/1471-2407-10-587. BMC Cancer. 2010. PMID: 20979647 Free PMC article.
-
Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context.Mol Cancer. 2008 Dec 16;7:92. doi: 10.1186/1476-4598-7-92. Mol Cancer. 2008. PMID: 19087308 Free PMC article.
-
Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas.Hered Cancer Clin Pract. 2011 Aug 12;9(1):6. doi: 10.1186/1897-4287-9-6. Hered Cancer Clin Pract. 2011. PMID: 21838856 Free PMC article.
-
An Unusual Combination: KRAS and BRAF Co-mutated Metastatic Colorectal Cancer.J Gastrointest Cancer. 2016 Jun;47(2):206-9. doi: 10.1007/s12029-015-9735-y. J Gastrointest Cancer. 2016. PMID: 26018827 No abstract available.
-
DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset.PLoS One. 2010 Nov 12;5(11):e13978. doi: 10.1371/journal.pone.0013978. PLoS One. 2010. PMID: 21103049 Free PMC article.
References
-
- Fang JY, Richardson BC. The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 2005;6:322–327. - PubMed
-
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70. - PubMed
-
- Santos E, Martin-Zanca D, Reddy EP, Pierotti MA, Della PG, Barbacid M. Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Science. 1984;223:661–664. - PubMed
-
- Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–954. - PubMed
-
- Cichowski K, Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell. 2001;104:593–604. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous